Geralyn Ritter

Geralyn Ritter is head of external affairs and ESG at Organon. In this role, she focuses on guiding and shaping how the company interacts with key stakeholders and the environment.

Articles

Pharma Giving is Still Strong Despite Post-Pandemic Shifts

Nevertheless, it’s time to reassess how to leverage for greatest impact.

2023 Proxy Season: Record Proposals, Sliding Support

Drug access leads list of issues raised by pharma shareholders.

Ratings and Rankings: ESG Fundamentals for Pharma Leaders

There is room to improve what good looks like across the industry.

Pharma Governance and the Quest for Gender Equity

Examining efforts to boost women representation on company boards.

Is ESG a ‘Protection Racket’ or Long-Term Value Contributor?

The validity of ESG-driven investment and reporting in healthcare.

Meeting the Moment: ESG Strategy and the Business of Resilience

How principles of both can help companies navigate future storms.